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Background: The interaction of MSP119 with the cupredoxin azurin inhibits the growth of Plasmodium falciparum in red
blood cells.
Results: Rusticyanin forms a well defined complex with MSP119 upon binding at the same surface area than inhibitory
antibodies.
Conclusion: Rusticyanin becomes an excellent therapeutic agent for malaria.
Significance: Knowing the rusticyanin-MSP119 interface will allow the design of novel antimalarial drugs.
The discovery of effective new antimalarial agents is urgently
needed. One of themost frequently studiedmolecules anchored
to the parasite surface is the merozoite surface protein-1
(MSP1). At red blood cell invasion MSP1 is proteolytically pro-
cessed, and the 19-kDa C-terminal fragment (MSP119) remains
on the surface and is taken into the red blood cell, where it is
transferred to the food vacuole and persists until the end of the
intracellular cycle. Because a number of specific antibodies
inhibit erythrocyte invasion and parasite growth, MSP119 is
therefore a promising target against malaria. Given the struc-
tural homology of cupredoxins with the Fab domain of mono-
clonal antibodies, an approach combining NMR and isothermal
titration calorimetry (ITC)measurementswith docking calcula-
tions based on BiGGER is employed on MSP119-cupredoxin
complexes. Among the cupredoxins tested, rusticyanin forms a
well defined complex with MSP119 at a site that overlaps with
the surface recognized by the inhibitory antibodies. The addi-
tion of holo-rusticyanin to infected cells results in parasitemia
inhibition, but negligible effects on parasite growth can be
observed for apo-rusticyanin and other proteins of the cupre-
doxin family. These findings point to rusticyanin as an excellent
therapeutic tool for malaria treatment and provide valuable
information for drug design.
Malaria is a widely spread disease causing morbidity and
mortality throughout a large part of the world. The increasing
resistance of Plasmodium falciparum, the causative agent of
the most deadly form of the disease, to current drugs has only
increased the urgency for finding new antimalarial agents (1, 2),
including an effective vaccine and new drug therapies (3, 4).
There are five Plasmodium species that infect humans, whereas
others infect other primates or rodents. Among this latter
group, rodent parasites such as Plasmodium yoelii provide use-
ful laboratory models for the study of malaria. The disease is
caused by the replication and multiplication of the asexual
blood stages in red blood cells. The merozoite form of the par-
asite invades the host cell, where it develops and replicates to
form several new merozoites that then burst out of the cell to
continue the cycle of invasion andmultiplication. The invasion
of red blood cells requires an initial recognition and binding
mediated by parasite surface ligands, followed by reorientation
and the formation of a moving junction between the erythro-
cyte and merozoite surfaces as the parasite enters the cell.
Merozoite surface protein-1 (MSP1)8 has been implicated in
this initial binding between parasite and host cell.
Located on the surface of the asexual blood-stage schizont
and merozoite, MSP1 is one of the most frequently studied
molecules of the parasite (5). It is synthesized as a 200-kDa
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precursor attached to the surface of the parasite via a glycosyl-
phosphatidylinositol anchor, which undergoes a two-step pro-
teolytic process: first, at merozoite release and then at erythro-
cyte invasion (6). As a result of this processing, the MSP1 is
cleaved into several polypeptides that are shed from the surface
in the final processing step, save a 19-kDa C-terminal fragment
(MSP119). MSP119 is retained on the parasite surface by the
glycosylphosphatidylinositol anchor and taken into the red
blood cell at invasion (7–9). The role of MSP119 in the subse-
quent intracellular development of the parasite is poorly under-
stood, although it is transferred to the developing food vac-
uole, where it remains until the end of the intracellular cycle
and is discarded in the residual body together with products
of hemoglobin digestion such as hemozoin (10). MSP119 is
considered a promising malaria vaccine candidate due to the
abundant evidence of specific antibodies inhibiting erythro-
cyte invasion and parasite growth, for instance, via the dis-
ruption of MSP1 proteolytic processing and intracellular
parasite development (11).
At the structural and functional levels,MSP119 is particularly
well conserved among Plasmodium species (Fig. 1) (12–17),
and its three-dimensional structure has been shown to consist
of two epidermal growth factor (EGF)-like domains in close
contact. A characteristic disulfide-bridge pattern (Fig. 1)makes
MSP119 highly resistant to proteases (19) and may explain why
MSP119 remains intact in the digestive food vacuole up to the
end of the intracellular cycle (10).
MSP1-specific immunoglobulins react with conformational
epitopes of MSP119. Some of these antibodies inhibit parasite
invasion of erythrocytes, whereas others do not. Fine structure
epitope mapping of different monoclonal antibodies (mAbs)
and the use of NMR methods indicates the binding of two
inhibitory antibodies to epitopes on one side of the molecule
near the interface between the two EGF domains, including
residues from both domains (20, 21). By contrast, non-inhibi-
tory neutral mAbs bind elsewhere on the molecule (15, 20).
Here, we have used MSP119 from P. yoelii, a rodent malaria
parasite used as a laboratory model for vaccine studies (22)
and for which both inhibitory and neutral antibodies have
been partially mapped on the structure (23, 24).9 Independ-
ently of the immunoglobulin class, complexes involving
MSP119 are kinetically rather stable with dissociation con-
stants in the micromolar to subnanomolar range (15, 25).10
Because the binding affinity is similar in all cases, it has been
assumed that the inhibitory effect depends mainly on steric
factors, namely, epitope location, rather than the nature of
the antibody.
The present study has been based on the structural homology
of cupredoxins with the Fab fragment of an antibody, as well as
on reports of a protein from this family interacting directly with
MSP119 and blocking the increase of parasitemia in human red
blood cells infected by P. falciparum, suggesting a promising
treatment (26, 27). We first used the DaliLite pairwise compar-
ison program to identify structural similarities between cupre-
doxins and the Fab fragment (28). A screening was then per-
formed combining NMR and ITCmeasurements with docking
calculations using BiGGER which indicated that, among the
cupredoxins tested, rusticyanin (Rc) provided the most effec-
tive binding to MSP119. The two proteins form a well defined
complex where Rc interacts at the interface between the two
MSP119 subdomains, at a site that overlaps with the surface
recognized by the inhibitory antibodies. Further, P. falciparum
growth is inhibited by the presence of Rc in red blood cell cul-
9 R. D. Curd and A. A. Holder, unpublished data.
10 M. J. Lock and A. A. Holder, unpublished data.
FIGURE 1.MSP119 protein. A, multiple sequence alignment of MSP119 with ClustalW2 (18) from a number of Plasmodium species. Sequences are colored by
percent identity: black (100%), dark gray (80%), light gray (60%), andwhite (50%). Secondary structure elements of P. yoeliiMSP119 are shown.Orange boxes
highlight cysteine residues that are conservedacrossdifferentPlasmodium species,whereas redboxeshighlight thosepresentonly inP. falciparum.Goldarrows
stand for disulfide bonds formed by cysteine residues. The main difference between P. falciparum MSP119 and homologs from other Plasmodium species
characterized to date lies in the disulfide bond pattern of the protein from the other species: one of the cysteine pairs in the first EGF domain is substituted by
a tryptophan and a nonpolar or aliphatic residue. B, ribbon representation of the lowest energy NMR structure of P. yoeliiMSP119 (BMRB accession number:
19233). Side chains of cysteine residues forming disulfide bridges are represented in gold.
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tures. Interestingly, the copper site plays a key role in complex
formation, because apo-Rc is not only unable to interact with
MSP119, but also to inhibit parasite invasion and development
in infected red blood cells.
EXPERIMENTAL PROCEDURES
Expression and Purification of Proteins—P. yoelii MSP119
(15N-labeled or unlabeled) was produced (essentially as
described previously (29)) from a synthetic gene optimized for
Pichia pastoris expression using as nitrogen source either
15NH4Cl or (NH4)2SO4 for labeled and unlabeled protein,
respectively. The 99-amino acid sequence corresponds to resi-
dues 1656–1754 of theUniProtKB entry P13828 containing the
N-terminal tag HHHHHHIEGR that has little effect on the
NMRspectrum (20). SecretedHis6-taggedMSP119was purified
from the culture medium by nickel affinity chromatography
(Ni-Sepharose 6 Fast Flow; GE Healthcare) and according to a
previously elaborated protocol (12).
All recombinant metalloproteins were expresed in Esche-
richia coli cultures in LB medium and purified according to
previously elaborated procedures, namelyAcidithiobacillus fer-
rooxidans Rc (30, 31),Nostoc sp. PCC 7119, Phormidium lami-
nosum and poplar plastocyanins (Pc) (32–34) and Pseudomo-
nas aeruginosa azurin (Az) (35).
NMR Spectroscopy—All protein samples were concentrated
in 10 mM potassium phosphate (pH 6.5) using Millipore 3000
NMWL centricons and microcons. MSP119 samples ranged in
concentration from 0.5 to 2 mM, whereas cupredoxins were
used in the range of 2–5 mM. All NMR samples contained 10%
D2O to adjust the lock signal. Reduction of the metal center in
samples of copper(I) cupredoxins was achieved by adding
sodium ascorbate, whereas oxidation of the metal center in
samples of copper(II) proteins was achieved using sodium fer-
ricyanide for Pc and Az, and sodium hexachloroiridate(IV) for
Rc. In all cases, the proteins were washed extensively to remove
the excess of the reducing/oxidizing agent.
NMR experiments were performed in a Bruker Avance 600
MHz spectrometer at 25 °C. The sequence-specific assignment
of the backbone amide groups of 15NMSP119 (BMRB accession
number: 19233) was achieved using standard backbone exper-
iments (HNCACB, HNCA, etc.) and was confirmed using
three-dimensional 1H-15N NOESY-HSQC and three-dimen-
sional 1H-15N total correlation spectroscopy-HSQC spectra.
The interaction of MSP119 with cupredoxins was followed by
acquiring two-dimensional 1H-15N HSQC spectra during the
titration of 0.5 mM 15N-MSP119 solutions with an increasing
amount of oxidized or reduced cupredoxins up to a final cupre-
doxin:MSP119 molar ratio of 4:1. The pH value of the sample
was verified after each titration step. Prolines, which are invis-
ible resonances in 15N HSQC spectra, are located at the posi-
tions 4, 15, 50, 61, 84, and 86, whereas Gly-1, Val-2, Glu-69, and
Asn-73 are unassigned residues. All data processing was per-
formed with Bruker TopSpin 2.0, and NMR analysis of line
broadening perturbations of the cupredoxin-bound MSP119
with respect to free malarial protein was performed in the
SPARKY program (36).
NMR Line Width Analysis—To estimate line widths, the
peaks were fitted to a Gaussian function for the 15N and 1H
dimensions using the program SPARKY with a 10,000 steps
minimization and a 0.05% tolerance. In the analysis of the line
widths (1/2), the overall broadening (1/2) obtained from
signals displaying only minor line broadening was first sub-
tracted from the line width of the corresponding signal. Then,
for each residue, the differences of line widths between free
and interacting MSP119 were calculated in every titration
series (1/2 Binding). The threshold value, used to identify a
specifically broadened residue when data from the titration series
were analyzed together, was defined as the average 1/2 Binding
for the system plus 2 standard deviations (2Sn1). The aver-
age 1/2 Binding and standard deviation were calculated for
all amides with values 10 Hz on the basis that data 10 Hz
clearly indicated a specifically broadened residue, and their
inclusion would bias the average to a higher value. Some
assigned signals of the free MSP119 HSQC spectrum overlap
(Val-9, Asn-87, and Cys-95) or exhibit very low intensity
(Gly-41 and Asn-42), so they could not be properly integrated
to include them in the line width analysis.
ITC—All ITC experiments were performed using VP-ITC
and Auto-ITC200 instruments (Microcal; GE Healthcare) at
25 °C titrating Rc with MSP119. The reference cell was filled
with distilledwater. The experiments consisted of 10-l or 2-l
injections of 0.3mMMSP119 solution in 10mMpotassiumphos-
phate buffer (pH 6.5) into the sample cell, initially containing
6.67 M Rc solution (reduced, oxidized, and apo forms) in the
same buffer. All of the solutions were degassed before the titra-
tions were performed. Titrant was injected at appropriate time
intervals to ensure the thermal power signal returned to the
base line prior to the next injection. To achieve homogeneous
mixing in the cell, the stirring speed was kept constant at 1000
rpm in the Auto-ITC200 and at 450 rpm in the VP-ITC. The
data, specifically the heat per injection normalized per mol of
injectant versus molar ratio, were analyzed with Origin 7
(Microcal) using a single-site binding model. Calibration and
performance tests of the calorimeter were carried out conduct-
ing CaCl2-EDTA titrations with solutions provided by the
manufacturer.
Molecular Docking Simulations—A soft docking algorithm
implemented in the BiGGER software package (37) was used to
determine in silico a model of the complexes MSP119-Az,
MSP119-Pc, and MSP119-Rc. The PDB coordinates files of
cupredoxins were 1JZG forAz (38), 1NIN for Pc (39), and 1A3Z
for Rc (40). For each run, 5000 docking geometric solutions
were generated based on the complementarity of the protein
surfaces. These solutions were evaluated and ranked according
to their “global score” and different interaction criteria includ-
ing electrostatic energy of interaction, relative solvation energy,
and the relative propensity of side chains to interact. For the
MSP119-Rc adduct, NMR restraints were introduced in the
docking calculations. All complexes graphic images were gen-
erated using the UCSF Chimera package (41).
P. falciparum Cultures—Synchronized P. falciparum 3D7
late stage trophozoites at 33–36 h were used. The final parasit-
emia and hematocrit were between 0.1–0.2 and 2%, respec-
tively. Red blood cells used for the assay were centrifuged to
remove the buffy coat and washed twice in RPMI 1640
medium so that no white blood cells were present. The cul-
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ture medium contained RPMI 1640 medium supplemented
with 5 g/liter albumax, 0.025 g/liter gentamycin, and 0.292
g/liter L-glutamine.
P. falciparumGrowth Inhibition Assay—Sterile 96-well black
tissue culture plates (Costar) were used routinely for every
assay. The holo- or apo-species of Rc and Nostoc Pc were
diluted in culture medium and used in duplicate wells for each
dilution (200, 100, 50, and 25M, respectively) in a final volume
of 100 l/well. Two control sets were used in duplicate wells,
one set with no added cupredoxin (positive control) and one
with uninfected red blood cells (negative control). The plates
were incubated at 37 °C for 48 h in a gas chamber flushed with
5% CO2, 5% O2, and 90% N2. After 48 h, supernatants were
removed from each well, replaced with fresh medium contain-
ing protein, and incubated for a further 48 h in the same man-
ner. At the end of the 96-h incubation, 25 l of SYBR Green I
dye (SYBR Green I nucleic acid gel stain 10,000, in dimethyl
sulfoxide from Invitrogen) in lysis buffer (1 l dye to 1 ml lysis
buffer), was added to each well and stored overnight at20 °C.
The lysis buffer contained Tris-HCl (20 mM, pH 8.0), EDTA (2
mM), Saponin (0.16% w/v) and Triton X-100 (1.6% v/v). Plates
were thawed at room temperature, and fluorescence intensity
was measured with a FLUO Star Omega microplate fluores-
cence reader (BMGLabtech). Values were expressed in relative
fluorescence units. Binding of SYBR Green is specific for para-
site DNA as mature erythrocytes lack DNA and RNA. Fluores-
cence intensity unit was converted to percentage (%) of growth
as follows: % growth (culture under Rc or Pc) (uninfected
RBC)/(culture with no Rc or Pc)  (uninfected RBC) 100,
where RBC are red blood cells.
FIGURE 2. Conserved structural motifs. A, ribbon representation of the Fab fragment of mAb G17.12 (PDB ID code 1OB1). Domain A is depicted in light gray
and domain B in gold. B, structural alignment of Az (upper, PDB ID code 1JZG) and A1 fragment of Fab (lower) built by DaliLite pairwise comparison server.
Matching regions, with a Dali Z-score of 2.9, appear in orange. C, ribbon representation of Rc (upper, PDB ID code 1A3Z) and Pc (lower, PDB ID code 1NIN). Dali
Z-scores for Rc and Pc are 2.6 and 3.1, respectively. Copper atoms are colored in blue.
FIGURE 3. Ab initio docking of cupredoxins with MSP119 performed by BiGGER. Left, Az. Center, Pc. Right, Rc. Light yellow spheres represent the geometry
centers ofMSP119 in the 100 best solutions generated for each complex. All cupredoxins are orientedwith respect to their copper center. Robertson diagrams
of the cupredoxins are colored according to secondary structures:-helices in red and-strands in blue. Copper atoms are represented as blue spheres and the
residues bonding to them are in gray sticks.
MSP119-Rusticyanin Complex
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RESULTS
Structural Similarities between Cupredoxins and the Fab
Fragment of a mAb—The Fab fragment crystal structure of
mAb G17.12 (15), shown to bind MSP119, is composed of two
domains, A and B, containing two regions, variable (symbolized
by 1) and constant (symbolized by 2), with the canonical
-sandwich fold of the immunoglobulin superfamily (Fig. 2A).
Consistent with previous reports, the DaliLite pairwise com-
parison program (28) identified significant structural similari-
ties between the A1 fragment of the mAb and copper-contain-
ing redox proteins with immunoglobulin fold, such as Az, Pc,
and Rc. In particular, the structural alignment between the A1
fragment and Az reveals a matching region, which is localized
mainly at the two antiparallel -sheets, as described previously
(26; Fig. 2B), and with a Dali Z-score of 2.9. For the two other
cupredoxins, Pc andRc, this structuralmatch is extended to the
loops connecting -strands yielding Z-scores of 3.1 and 2.6,
respectively (Fig. 2C).
Given the structural similarity between various cupredoxins
and the Fab fragment, ab initio docking approaches were per-
formed with no experimental restraints (Fig. 3) to explore the
capability of the metalloproteins to interact with MSP119 from
P. yoelii. MSP119 is well conserved among the species with
50% sequence identity (Fig. 1A), with conserved three-di-
mensional structure and common functional features (17). We
used the BiGGER rigid docking algorithm to generate sets of
possible orientations for the different cupredoxin probes
around MSP119 (the target). Fig. 3 shows the distribution of
MSP119 mass centers resulting from the 100 best solutions
from each computation around the corresponding copper pro-
tein. For Az and Pc, we observe a remarkably broad dispersion
of the MSP119 geometry centers, suggesting the lack of specific
surface complementarity. By contrast, molecular docking for
the Rc-MSP119 interaction indicates that MSP119 explores a
well defined area of Rc surrounding its copper center.
MSP119 Interactions with Cupredoxins by NMR—The
MSP119-cupredoxin interaction was monitored by recording
two-dimensional 15N HSQC NMR spectra on 15N-MSP119,
both free and following the addition of Az, Pc, or Rc. The
absence of changes inMSP119 resonances, either chemical shift
perturbations or line broadening, indicates no detectable bind-
ing to Az and Pc in any of their oxidation states (Fig. 4, top and
middle panels). By contrast, line width changes of certain
MSP119 amide signals upon addition of Rc(Cu) suggest a spe-
cific MSP119-Rc interaction (Fig. 4, bottom panel). Such obser-
vations coincide with ab initio docking simulations performed
(Fig. 3) which suggested a well defined complex only between
Rc and MSP119.
To probe in greater detail the interaction of MSP119 with
either oxidized or reduced Rc, we analyzed the line widths of
MSP119 resonances from 15N HSQC spectra across several
titrations. Binding to Rc results in general signal broadening
due to the increase in the rotational correlation time ofMSP119
when interacting with Rc. In addition, several MSP119 back-
bone amides clustered in one area of the structure undergo
larger changes in line widths (1/2 Binding) upon Rc binding
(Figs. 5 and 6). These resonances are expected to be at or in the
proximity of the area of MSP119 interacting with Rc. To selec-
tively define resonances most likely to be part of the interface,
threshold values (specifically, 1/2 Binding  5Hz for 15N
and  11Hz for 1H dimension) were set (see “Experimental
Procedures”). As expected, the distribution of line width
changes (1/2) becomes broader as the Rc:MSP119 ratio
increases (data not shown).
FIGURE4.NMRtitrationsof 15NMSP119with reducedcupredoxins.Top, Az
from P. aeruginosa. Middle, Pc from Nostoc sp. PCC 7119. Bottom, Rc from A.
ferrooxidans. Superimposition of 15N HSQC spectra of free MSP119 (magenta)
andafter addingoneof three cupredoxins (blue) at a cupredoxin:MSP119 ratio
of 4:1 is shown. Arrows point out those residues that experience substantial
broadening. Negligible binding to MSP119 was observed upon adding ali-
quots of Pc and Az.
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At the Rc(Cu1):MSP119 ratio of 1.5:1, 14 amino acids show
considerable 15N line width changes in MSP119 HSQC spectra
(Fig. 5, A and B). These residues are distributed mainly along
two regions of MSP119, namely, at the beginning of N-terminal
EGF domain involving Asp-3, Lys-5, His-6, Val-7, Asp-10, and
at the end of C-terminal domain comprising Thr-85, Ala-88,
Tyr-89, Phe-94, and Ser-97. In addition, Asp-24, Asp-25, and
Arg-31 at the two first antiparallel -strands, along with Cys-
59, are also altered. Fig. 5C shows the map of MSP119 residues
affected by Rc addition, with colors corresponding to line
broadening in the 15N dimension. The sequential stretches of
residues detailed above form the main cluster on the MSP119
surface, which surrounds the two EGF domain interface. Inter-
estingly, some of these affected residues (Asp-24, Asp-25,
Arg-31 and Cys-59) are located at the rear of the protein (Fig.
5C).WhereasAsp-24 andAsp-25 are close to amino acids at the
N terminus, Arg-31 and Cys-59 lie near Phe-94. Because these
four residues are adjacent to others placed at the EGF domain
interface and involved in direct contact with Rc, these line
width perturbations are probably a secondary effect of binding.
Similar conclusions may be inferred from 1H line width analy-
sis, although protons aremore sensitive to broadening (data not
shown).
NMR titration of oxidized Rc on MSP119 results in signifi-
cant MSP119 line width perturbations at a Rc(Cu2):MSP119
ratio of 4:1, at which some signals broaden beyond the detec-
tion limit (Fig. 6A). The MSP119 resonances affected by
Rc(Cu2) binding involve both N-terminal (Asp-3, Lys-5, Asp-
10, and Asp-13) and C-terminal (Cys-79, Thr-85, Tyr-89, Gly-
92, Phe-94, Ser-97, and Ser-98) regions, as described for the
reduced system at a Rc(Cu1):MSP119 ratio of 1.5:1. An addi-
tional stretch (Phe-21 to Asp-24, Gly-26, Glu-29, Arg-31, and
Cys-59) is also perturbed whereas His-6, Val-7, Asp-25, and
Thr-27 were residues over the detection limit (Fig. 6A). Nota-
bly, the strength of the broadening observed for a 4:1 Rc(Cu2):
MSP119 ratio is comparable with the one observed at a 1.5:1
Rc(Cu1):MSP119 ratio, indicating that MSP119 binds more
weakly to the oxidized Rc. However, the MSP119 interacting
surface involved in Rc recognition at a Rc:MSP119 ratio of 4:1 is
independent of the cupredoxin redox state (Fig. 6).
Binding of MSP119 to Holo-Rc by ITC—ITC measurements
reveal thatMSP119 binds to Rc either in its reduced or oxidized
state with a 1:1 stoichiometry at 25 °C (Fig. 7). Notably, the
interaction of MSP119 with Rc(Cu1) is exothermic with a dis-
sociation affinity constant (Kd) of 2 M, whereas that with
Rc(Cu2) is an endothermic process with lower binding affinity
FIGURE 5.NMR titration of 15NMSP119with reducedRc.A,
15N linewidth differences (15N1/2 Binding) between free and Rc-boundMSP119. The Rc:MSP119
ratios are 0.5:1 (red), 1:1 (gray), and 1.5:1 (blue). B, superposition of 15N HSQC spectra of free MSP119 (magenta) and bound to Rc (blue) in a Rc:MSP119 ratio of
1.5:1. A subset of three representative resonances is labeled in black. C, map of MSP119 interface upon binding to Rc. MSP119 surface is rotated 90° around the
vertical axes in each view. Residues are colored according to their 15N 1/2 Binding (Hz): the resonances that undergo the largest broadening (5 Hz) are
orange, and the signals with a significant line width over the detection limit5 Hz are yellow. The limit of 5 Hz corresponds to a threshold value relative to the
average plus 2-fold the S.D. (1/2 Binding1/2 Binding 2Sn1). Residues with no line width perturbation are marked in blue, whereas prolines are in
gray.
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(Kd  25 M) (Table 1). Such differences in Kd values are in
agreement with NMR titrations and suggest thatMSP119 binds
to reduced Rc with a greater affinity than to oxidized Rc.
Further experiments need to be performed to explain the
opposite sign in the enthalpy of both processes as it could be
related to (i) changes in the protonation/deprotonation
equilibrium of ionizable groups of the interacting proteins;
(ii) variations in the hydrogen-bonding networks; (iii) differ-
ences in water arrangement in the vicinity of oxidized or
reduced cofactors; and (iv) slight conformational modifica-
tions altering the number of solvent molecules excluded
from the protein interface.
FIGURE 6. Comparison between NMR titrations of 15NMSP119 with either oxidized or reduced Rc at Rc:MSP119 ratio of 4:1.Most of the MSP119 signals
in binding to Rc(Cu1) are broadening over the detection limit at the Rc:MSP119 ratio of 4:1, suggesting that MSP119 binds reduced Rcwith a higher affinity. A,
upper, overlap between 15NHSQC spectra of freeMSP119 (magenta) and oxidized Rc-boundMSP119 (blue). A, lower, map ofMSP119 in the presence of oxidized
Rc. B, the same as Awith reduced Rc. The 90°-rotated surface representations ofMSP119 show residues colored according their
15N1/2 Binding following the
same color code as in Fig. 5C. Those residues broadened beyond the detection limit are highlighted in red.
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The Case of Apo-Rc—To determine the role of the copper
center, NMR and ITC titrations were carried out usingMSP119
and apo-Rc. Surprisingly, NMR titrations showed no substan-
tial line width changes even at an apo-Rc:MSP119 ratio of 4:1
(Fig. 8). The finding was further corroborated by ITCmeasure-
ments, as the weak calorimetric profile suggests a lack of inter-
action (Fig. 8). Altogether, these data indicate the relevance of
the copper center in the binding to MSP119. Despite the small
structural differences in cupredoxins reported previously in
solid state, there exists a high degree of mobility of the metal-
binding loops in solution in the apo form, as recently demon-
strated by NMR (42, 43). The different pattern between apo-
and holo-Rc versus MSP119 could be related with the found
differences in the dynamics of this site in the two forms.
Docking Simulations with BiGGER—Along with the ab initio
docking calculations run on the MSP119-Rc(Cu) complex,
revealing how the MSP119 mass center docks on the Rc metal
crevice (Fig. 3), an NMR-restrained docking with BiGGER was
also performed. Line width data for those MSP119 residues in
contact with Rc at a Rc:MSP119 ratio of 1.5:1 were included in
the run. The output is a set of docked solutions that can be
ranked according to the BiGGER global score or individual
scores, such as hydrophobic criteria, electrostatics, and geo-
metrical parameters. Fig. 9 shows the best 100 solutions, as
represented by Rc geometry centers, according to the global
and hydrophobic scores from the program (Fig. 9A). The best
scoring models predicted by restrained docking reveal how
MSP119 leans its EGF domain interface to approach Rc (Fig.
9A). Indeed, the proximity of the surfaces on both proteins in
the complex is shown in the space-filling representation (Fig.
9A). In addition to the copper center, loops connecting Rc
-strands are in close contact with MSP119. A deep analysis of
the complex interface predicted by docking points to theN-ter-
minal andC-terminal regions of theMSP119 as driving complex
formation as someNMR restraints are satisfied (Fig. 9B). In the
model reported, some electrostatic interactions occur (Fig. 9C)
because Rc residues Lys-81 and Lys-116 are close toGlu-91 and
Glu-83 in MSP119. Furthermore, Lys-5 of MSP119 can interact
with Glu-9 of Rc, although the Glu is partially buried. The Rc
interaction surface ismainly hydrophobic with the exception of
a single positive spot, Lys-81 and Lys-116, surrounded by Phe-
83, Gly-82, and Trp-7 and the copper center, which, in turn, is
enclosed by Met-99, Val-98, and Pro-141. This interaction
mode resembles those of the copper protein Pc and cytochrome
c6 with their photosynthetic partners, cytochrome f and photo-
system I. In such complexes, Pc and cytochrome c6 use the
hydrophobic site surrounding the copper center and the heme
group (site 1) as well as their charged patch (site 2; 44, 45).
Inhibition of P. falciparumGrowth byHolo-Rc—Toassess the
physiological relevance of the MSP119 binding to Rc, the
growth of P. falciparum within red blood cells was followed in
FIGURE 7. ITC titrations of MSP119 with both redox states of Rc. Binding assays of the complexes between MSP119 and reduced (left) or oxidized Rc (right)
are shown. Thermograms are shown at the top and binding isotherms at the bottom, along with the dissociation constant (Kd expressed in M), enthalpy (H
in kcal/mol). The stoichiometry value (n) was fixed to avoid degeneracy in the nonlinear regression data analysis. Typical relative errors are 20–25% for the
dissociation constant and 5–10% for the stoichiometry.
TABLE 1
Thermodynamic values inferred from ITC experiments
The affinity of a protein-protein interaction is defined by the Gibbs energy of the
binding: GRT ln Ka. G has two different contributions, H and S, accord-
ing to the equation: G  H  TS, thus several combinations of those values
could yield similar binding affinities. The complex formation is entropically driven
in both cases, being the enthalpic contribution to the binding unfavorable (15 kcal/
mol with oxidized Rc) or only slightly favorable (1.7 kcal/mol with reduced Rc).
MSP119 complex G H S Kd
kcal/mol kcal/mol kcal/mol M
Oxidized Rc 6.3 15.0 21.3 25.0
Reduced Rc 7.8 1.7 6.1 2.0
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the presence of either holo- or apo-Rc (see “Experimental Pro-
cedures”). The addition of holo-Rc to infected cells resulted in
parasitemia inhibition, as culture growth decreased signifi-
cantly (Fig. 10) at a concentration of 100 M until the point of
complete inhibition at 200 M holo-Rc. In contrast, the apo
form even at high concentrations did not have a significant
effect on P. falciparum growth. These data fully corroborate
previous observations using NMR or ITC as much as apo-Rc is
unable to bind to MSP119.
To discard the theory that such a parasitemia inhibition
could be ascribed to the well known apoptotic role of several
cupredoxins (46, 47), control experiments were run with the
holo- or apo-form of Pc. Holo-Pcwas chosen as it does not bind
toMSP119, as inferred from the herein presented NMR screen-
ing (see above), but it is structurally very similar to Rc: the two
proteins belong to the type I blue copper-protein family, with
almost identical folding and tetrahedral copper center. Upon
addition of either holo- or apo-Pc (25 M) under the same cul-
ture conditions, the Plasmodium growth first slightly decays to
further reach a constant value until the end of the experiment.
So the Plasmodium growth does not depend on protein con-
centration (the percentage of growth is maintained at
approximately 70% even at 200 M Pc) and is practically the
same with either holo- or apo-Pc. Altogether these results
indicate that holo-Rc inhibits parasitemia upon specific
binding to MSP119.
FIGURE 8. NMR and ITC titrations of MSP119 with apo-Rc. A,
15N line
width differences (15N1/2Binding) between free MSP119 and in the pres-
ence of apo-Rc. The apo-Rc:MSP119 ratios were 1:1 (red), 1.5:1 (gray), and
4:1 (blue). B, overlap between 15N HSQC spectra of free MSP119 (magenta)
and in the presence of apo-Rc (blue) at an apo-Rc:MSP119 ratio of 4:1. C, ITC
thermogram obtained from the apo-Rc-MSP119 titration, revealing the
lack of binding between both proteins because of the flat calorimetric
profile.
FIGURE 9. BIGGER molecular docking of the MSP119-Rc complex. A, left,
best 100 models with the lowest energy values after alignment of MSP119
molecules with Rc geometry centers represented by spheres. Ribbon (center)
and space-filling (right) representations for the best model are shown in the
sameorientation as on the left. MSP119 is represented in dark graywhereas Rc
is in light blue. B, interface residues of theMSP119-Rc complex. MSP119 and Rc
are independently rotated 90° to the top and to the bottom, respectively,
with regard to their orientation in A. Contacting residues are depicted in light
yellow for theMSP119 anddarkblue for Rc.C, electrostatic potential surfacesof
MSP119 (upper) and Rc (lower) with the same orientations as in B. The electro-
static potential surfaceswere createdwith a color ramp for positive (blue) and
negative (red) potentials at 300mM ionic strength. The potentials were calcu-
lated in Chimera software (41).
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DISCUSSION
Proteins from the cupredoxin family have demonstrated
antimalarial activity and potential as therapeutic agents (26,
27).We have shown here that the cupredoxin rusticyanin inter-
acts with MSP119 with micromolar Kd, forming a well defined
complex. The interaction takes place on the same surface as
that targeted by inhibitory antibodies, suggesting that a similar
mechanism could take place. Its strength is dependent on the
presence and, to a lesser extent, on the oxidation state of the
metal center, which is consistent with the need for an intact
interaction surface and charge conservation. Furthermore, we
have observed the inhibition of P. falciparum parasitemia in
infected cells where holo-Rc is present as a result of the inter-
action with MSP119. However, negligible effect on parasite
growth could be observed for apo-Rc and Pc forms.
MSP119 signals show slow exchange in the presence of the
Fab fragments of the inhibitory mAb12.8 and mAb12.10, indi-
cating the kinetic stability of complexes involvingMSP119 with
binding affinity constants in the micromolar to subnanomolar
range (20). Rc binds specifically with a Kd of 2 M to the inter-
face between the two MSP119 EGF domains, overlapping the
surface recognized by these inhibitory antibodies (20, 21), as
indicated by our NMR-based mapping. A detailed comparison
of MSP119 bound to either Rc or mAb12.10 and mAb12.8
reveals that the common interacting surfaces are located in the
first EGF domain along with the first -sheet and at the end of
the second EGF domain. Interestingly, these regions ofMSP119
form a shallow pocket (Fig. 1B) that may have a role in erythro-
cyte invasion (21). In addition, these residues involved in the
formation of protein complexes withMSP119 are distributed in
three segments: His-6 to Val-9, Lys-16 to Arg-22, and Tyr-89 to
Cys-95 (numbering according to the P. yoeliiMSP119 sequence;
Fig. 1A), and they are strongly conserved in different species
(21), supporting the idea that this is a functional site. The pres-
ence of additional perturbed residues identified in this study
may be explained by the flat structure of MSP119 (5) because
perturbations as a result of a protein-protein interactionmay be
transferred from one MSP119 face to the other.
Another point of interest arising from this study is the mode
of interaction of MSP119 with Rc, compared with the interac-
tion with mAbs. The study took as starting point a structural
alignment of Rc with the Fab fragment of the non-inhibitory
mAb G17.12 whose interaction with MSP119 has been solved
through x-ray crystallography (15). The similarities with the
-barrel, as well as the loops connecting them, are clear (Fig. 2).
However, the relative orientation between the mAb and
MSP119 does not match that defined for the MSP119-Rc com-
plex (Fig. 11A). In contrast, the models of mAb12.8-MSP119
and mAb12.10-MSP119 complexes built by Autore et al. (48)
using NMR-based docking calculations match well with the
Rc-MSP119 model reported here. In looking for structural sim-
FIGURE 10. Inhibition ofP. falciparumgrowthbyRc. Percentage of parasite
growth was measured in the presence of either holo-Rc (filled circles), apo-Rc
(open circles), holo-Pc (filled stars) or apo-Pc (open stars) at varying concentra-
tion (see “Experimental Procedures”). Parasite cultures were incubated with
theRcorPc forms for a96-hperiod,with amediumchangeafter 48h. Cultures
in the absence of cupredoxin were used as a positive control.
FIGURE 11. Comparison of complexes containing MSP119. A, MSP119-mAbG17.12 crystallographic structure (PDB ID code 1OB1; 15). Domain A1 of the
noninhibitory mAbG17.12 is represented in light gray, whereas P. falciparumMSP119 is in purple. B, MSP119-mAb12.10 complex, whose PDB coordinates were
kindly provided by Autore et al. (48). Domain A1 of the inhibitorymAb12.10 and P. falciparumMSP119 are colored as in A. C, MSP119-Rc complex studied in this
work. P. yoelii MSP119 is depicted in dark gray and Rc in light blue. Copper center is represented by a blue sphere. Matching regions between mAbG17.12 or
mAb12.10 and Rc after structural alignment using DaliLite are depicted in orange. The 180°-rotated views for both MSP119-mAb12.10 and MSP119-Rc com-
plexes are shown.
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ilarities between Rc and mAb12.10 with the DaliLite pairwise
comparison server, the Z-score 2.8 (Fig. 11, B and C) suggested
strong structural similarities, especially in the loops that inter-
act with MSP119. In this paper, MSP119 complexes with
mAb12.10 and Rc demonstrate (Fig. 11) a similar MSP119 ori-
entation with respect to the other molecule (mAb12.10 or Rc)
within each complex. The A1 region of mAb12.10 forms the
main interaction with MSP119, similar to the structurally
related region of Rc, especially at the level of -strand connect-
ing loops. As proposed byAutore et al. (48), a positively charged
electrostatic spot on the antibody surface is required in the
interaction and binding toMSP119. A similar positively charged
area is located on the Rc surface, Lys-81 and Lys-116 in the
complex interface, as inferred from our docking simulations
(Fig. 9C). The Rc-MSP119 interface also involves hydrophobic
contacts in the region surrounding the Rc copper center that
presumably plays a key role in complex formation, as indicated
by the NMR and ITC experiments. Reduced Rc binds MSP119
more efficiently than the oxidized form, suggesting that both
electrostatic potential properties and protein folding depend
on the metal redox state. This effect is even more drastic for
apo-Rc, which is unable to interact with MSP119.
The practical significance of these observations can be found
in the potential antimalarial role of the binding of Rc toMSP119
on the parasite surface, thereby blocking parasite growth and
interfering directly with parasite invasion of red blood cells. In
fact, the interaction might sterically interfere with the recogni-
tion between MSP1 and an erythrocyte surface molecule or
with the proteolytic processing of MSP1, which occurs during
invasion and can be inhibited by antibodies binding toMSP119.
Such a role has been shown previously in the drug suramin (49).
An alternative hypothesis, based on the fact that MSP119 is
internalized with the malaria parasite during invasion and then
trafficked to the food vacuole where it persists until the end of
the next intraerythrocytic cycle (10), is that MSP119-bound Rc
would be internalized and interfere with MSP119 functioning
inside the cell, as shown for an antibody (11). Supporting this
possibility, it has been reported that Rc is not only able to enter
mammalian cells, but also to induce caspase-8-mediated apo-
ptosis and/or to inhibit the cell cycle (47). Furthermore and
unlike other cupredoxins, Rc is a copper protein with high acid
stability and is biologically functional at a pH below 1.0 (50).
The extreme acid stability of Rc may be important in under-
standing its function of blocking MSP119 because pH is4.5–
5.5 inside the Plasmodium food vacuole. Altogether, Rc could
be an excellent therapeutic tool for malaria treatment and
expand our understanding of MSP119 function. In this way, as
well, it could provide beneficial information for drug design.
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